Edesa Biotech, Inc. - EDSA

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$4.332M
QoQ value delta ($000)
-$2.76M (-38.92%)
Implied price effect (QoQ)
-42.47%
Shares
Total shares
3,052,673
QoQ shares delta
+177,780 (+6.18%)
Total shares held by funds (by quarter)

Market chart (EDSA)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Stonepine Capital Management, LLC 976 687,500 0.71%
Rubric Capital Management LP 976 687,500 0.01%
Velan Capital Investment Management LP 976 687,500 0.57%
Nantahala Capital Management, LLC 887 625,000 0.03%
DRW Securities, LLC 190 134,222 0.01%
CITADEL ADVISORS LLC 77 53,630 0.0%
DIADEMA PARTNERS LP 76 54,025 0.01%
GEODE CAPITAL MANAGEMENT, LLC 67 46,537 0.0%
VANGUARD GROUP INC 54 37,600 0.0%
STATE STREET CORP 27 18,679 0.0%
Persistent Asset Partners Ltd 17 12,319 0.01%
MORGAN STANLEY 3 2,300 0.0%
Tower Research Capital LLC (TRC) 3 2,554 0.0%
ROYAL BANK OF CANADA 2 1,659 0.0%
UBS Group AG 1 1,362 0.0%
BANK OF AMERICA CORP /DE/ 0 52 0.0%
DANSKE BANK A/S 0 1 0.0%
Global Retirement Partners, LLC 0 86 0.0%
Banque Cantonale Vaudoise 0 3 0.0%
TD Waterhouse Canada Inc. 0 142 0.0%
LRI Investments, LLC 0 1 0.0%
Dogwood Wealth Management LLC 0 1 0.0%